ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

35,087Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 2888

$1.53M Total Retail Price of All Prescriptions

Rank: 65 out of 2888

1,165 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 1,165 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 29,960 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LISINOPRIL 1,773 1,514 1 3
LOVASTATIN 1,635 1,398 10 2 41
AMLODIPINE BESYLATE 1,277 1,153 3 5
OMEPRAZOLE 1,108 953 4 7
LEVOTHYROXINE SODIUM 1,081 942 5 1
METFORMIN HCL 985 778 6 8
SIMVASTATIN 867 745 7 2
ENALAPRIL MALEATE 857 729 8 49
METOPROLOL TARTRATE 846 745 9 10
CIPROFLOXACIN HCL 834 689 10 47
LOSARTAN POTASSIUM 833 730 11 18
GLIMEPIRIDE 832 652 12 36
ALENDRONATE SODIUM 759 719 13 23
TRAMADOL HCL-ACETAMINOPHEN 591 512 14 95
HYDROCHLOROTHIAZIDE 579 467 15 15
CLONIDINE HCL 515 418 16 39
FUROSEMIDE 506 437 17 6
GLYBURIDE-METFORMIN HCL 443 388 R 18 64
HYDROCODONE-ACETAMINOPHEN 429 377 S3 19 4
NEXIUM 428 378 20 19
ACTOS 424 373 21 108
NAPROXEN 419 341 22 80
GLYBURIDE 393 343 R 23 58
AVODART 391 354 24 151
CLOTRIMAZOLE-BETAMETHASONE 382 321 25 136
CLOPIDOGREL 380 336 26 30
GLIPIZIDE 368 316 27 50
VERAPAMIL ER 356 306 28 104
FINASTERIDE 354 338 29 102
DIOVAN 331 294 30 35
ZOLPIDEM TARTRATE 324 307 31 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 320 276 32 28
DOXAZOSIN MESYLATE 319 293 33 94
FAMOTIDINE 302 252 34 75
TAMSULOSIN HCL 277 260 35 29
PLAVIX 267 232 36 40
CILOSTAZOL 251 192 37 165
ATENOLOL 238 223 38 25
TRAMADOL HCL 237 211 39 16
ATORVASTATIN CALCIUM 227 172 40 9
PREDNISONE 207 171 41 42
DONEPEZIL HCL 206 200 42 26
TRIAMTERENE-HCTZ 200 185 43 63
METOPROLOL SUCCINATE 196 140 44 11
DICLOFENAC SODIUM 194 175 45 141
DIOVAN HCT 179 162 46 61
PANTOPRAZOLE SODIUM 179 165 46 33
ALLOPURINOL 178 141 48 37
ACETAMINOPHEN-CODEINE 176 172 S3 49 147
ACTONEL 170 165 50 149
CYCLOBENZAPRINE HCL 168 125 R 51 68
SULFAMETHOXAZOLE-TRIMETHOPRIM 168 125 51 88
CITALOPRAM HBR 167 116 53 24
IBANDRONATE SODIUM 164 160 54 272
CARVEDILOL 159 135 55 21
IBUPROFEN 158 120 56 87
LANTUS 155 117 57 45
LOSARTAN-HYDROCHLOROTHIAZIDE 152 128 58 46
PRAVASTATIN SODIUM 150 119 59 12
NIFEDIPINE ER 145 141 60 76
BYSTOLIC 143 129 61 99
SERTRALINE HCL 142 80 62 27
CIMETIDINE 140 117 10 63 455
AMITRIPTYLINE HCL 138 107 R 64 74
GABAPENTIN 137 123 65 13
WARFARIN SODIUM 135 119 66 22
MELOXICAM 135 123 66 31
JANUVIA 133 100 68 48
ISOSORBIDE MONONITRATE ER 128 105 69 51
DICLOFENAC POTASSIUM 127 116 70 291
POTASSIUM CHLORIDE 120 83 71 14
CRESTOR 118 105 72 20
DIGOXIN 118 115 72 55
PIOGLITAZONE HCL 116 107 R 74 248
METOCLOPRAMIDE HCL 115 98 75 116
LANSOPRAZOLE 115 87 75 213
PENTOXIFYLLINE 107 98 77 286
OXYBUTYNIN CHLORIDE 105 96 78 124
SUCRALFATE 95 82 79 187
FENOFIBRATE 93 64 80 65
BONIVA 91 90 81 319
LANTUS SOLOSTAR 87 78 82 92
SINGULAIR 85 71 83 85
LEFLUNOMIDE 79 72 84 340
MECLIZINE HCL 77 70 85 122
PHENYTOIN SODIUM EXTENDED 77 44 85 128
INSULIN SYRINGE 76 50 87 86
ATELVIA 76 75 87 201
RANITIDINE HCL 74 74 89 56
TERBINAFINE HCL 74 61 89 328
PAROXETINE HCL 74 64 89 84
VYTORIN 73 70 92 155
LIPITOR 73 65 92 78
CLOTRIMAZOLE 72 55 94 294
SULINDAC 70 65 95 404
MOMETASONE FUROATE 66 48 96 268
SPIRONOLACTONE 65 64 97 70
ONGLYZA 62 49 98 210
HYDRALAZINE HCL 62 37 98 59
HUMULIN N 60 41 100 267
SURE COMFORT 59 34 101 276
NITROFURANTOIN MONO-MACRO 58 55 102 162
TRICOR 58 56 102 91
FOSINOPRIL SODIUM 57 57 104 400
NOVOLIN N 57 36 104 255
NYSTATIN-TRIAMCINOLONE 55 51 106 243
EVISTA 55 48 106 125
CLINDAMYCIN HCL 55 32 106 253
CEFPROZIL 53 43 109 344
GLIPIZIDE ER 52 51 110 107
AMIODARONE HCL 52 51 110 167
GENTAMICIN SULFATE 52 38 110 320
PEN NEEDLE 51 48 113 110
LEVOFLOXACIN 50 43 114 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 24, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.